Herein, with the aim to enlarge the arsenal of pharmacological tools to inhibit MICAL2, starting from CCG-1423 molecular structure (1, Figure 1), a small library of diverse analogues was synthetized and biologically evaluated on different MICAL2-expressing ECs and on cancer cell lines in which MICAL2 gene was knocked down [7]. This evidence concerns the gene MICAL2 and cancer.